BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28588640)

  • 1. Compounds from
    Wang X; Tao R; Yang J; Miao L; Wang Y; Munyangaju JE; Wichai N; Wang H; Zhu Y; Liu E; Chang Y; Gao X
    Evid Based Complement Alternat Med; 2017; 2017():6438013. PubMed ID: 28588640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
    Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
    Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen.
    Wang X; Zhu J; Yan H; Shi M; Zheng Q; Wang Y; Zhu Y; Miao L; Gao X
    Eur J Pharmacol; 2021 Sep; 907():174251. PubMed ID: 34129879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells.
    Maggiolini M; Recchia AG; Carpino A; Vivacqua A; Fasanella G; Rago V; Pezzi V; Briand PA; Picard D; Andò S
    J Mol Endocrinol; 2004 Jun; 32(3):777-91. PubMed ID: 15171712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.
    Miao L; Jiao C; Shao R; Qi Y; Fan G; Li X; Wang Y; Zhu Y; Zhang J; Gao X
    Toxicol Appl Pharmacol; 2019 Oct; 381():114637. PubMed ID: 31238046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.
    Zhang P; Hu WL; Cheng B; Zeng YJ; Wang XH; Liu TZ; Zhang WB
    Int Urol Nephrol; 2016 Mar; 48(3):325-33. PubMed ID: 26685888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators.
    Yu S; Wang MW; Yao X; Chan FL
    Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs.
    Pelletier G; Labrie C; Labrie F
    J Endocrinol; 2000 May; 165(2):359-70. PubMed ID: 10810300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.
    Song L; Shen W; Zhang H; Wang Q; Wang Y; Zhou Z
    Bosn J Basic Med Sci; 2016 Jul; 16(3):201-8. PubMed ID: 27294569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J
    J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of
    Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of sex hormones on genioglossal muscle activities, estrogen and androgen receptor expression in adult rat].
    Qi J; Liu YH; Wang F; Shao X; Song WH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Feb; 42(2):85-9. PubMed ID: 17462152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
    Ishikura N; Kawata H; Nishimoto A; Nakamura R; Tsunenari T; Watanabe M; Tachibana K; Shiraishi T; Yoshino H; Honma A; Emura T; Ohta M; Nakagawa T; Houjo T; Corey E; Vessella RL; Aoki Y; Sato H
    Int J Oncol; 2015 Apr; 46(4):1560-72. PubMed ID: 25634071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
    Kim HJ; Park YI; Dong MS
    Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.